We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$37.2B
AUM Growth
-$2.7B
Cap. Flow
-$1.95B
Cap. Flow %
-5.24%
Top 10 Hldgs %
6.97%
Holding
3,402
New
430
Increased
1,052
Reduced
1,183
Closed
472

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$275M
2
NFLX icon
Netflix
NFLX
+$254M
3
MSFT icon
Microsoft
MSFT
+$242M
4
QCOM icon
Qualcomm
QCOM
+$236M
5
SBUX icon
Starbucks
SBUX
+$232M

Sector Composition

Rank Sector Weight
1 Technology 17.08%
2 Healthcare 12.88%
3 Consumer Discretionary 11.39%
4 Financials 10.88%
5 Industrials 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLX icon
2726
Protalix BioTherapeutics
PLX
$194M
$78.5K ﹤0.01%
47,300
-7,825
-14% -$14K
SNCE
2727
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$78.4K ﹤0.01%
9,804
+6,475
+195% +$38.5K
TORO icon
2728
Toro Corp
TORO
$211M
$77.7K ﹤0.01%
13,300
-5,000
-27% -$26.6K
APYX icon
2729
Apyx Medical
APYX
$130M
$76.5K ﹤0.01%
23,900
SCOR icon
2730
Comscore
SCOR
$73.6M
$76.5K ﹤0.01%
6,229
-2,565
-29% -$36.2K
CIA icon
2731
Citizens
CIA
$200M
$76.1K ﹤0.01%
26,698
CNTA
2732
DELISTED
Centessa Pharmaceuticals
CNTA
$75.1K ﹤0.01%
11,600
+500
+5% +$3.42K
RVPH
2733
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$74.7K ﹤0.01%
765
-51
-6% -$4.75K
CRDF icon
2734
Cardiff Oncology
CRDF
$77.6M
$74K ﹤0.01%
53,267
-39,965
-43% -$67.4K
KLRS
2735
Kalaris Therapeutics
KLRS
$97.6M
$74K ﹤0.01%
+1,497
New +$102K
VRM icon
2736
Vroom Inc
VRM
$51.1M
$74K ﹤0.01%
826
+653
+377% +$82.3K
REKR icon
2737
Rekor Systems
REKR
$80.3M
$73.9K ﹤0.01%
+26,200
New +$79.9K
LYEL icon
2738
Lyell Immunopharma
LYEL
$361M
$73.4K ﹤0.01%
2,495
-295
-11% -$14K
GORO icon
2739
Goldgroup Mining
GORO
$266M
$72K ﹤0.01%
168,285
+141,572
+530% +$75.7K
CTLP
2740
DELISTED
Cantaloupe
CTLP
$71.9K ﹤0.01%
+11,500
New +$84.3K
ETWO.WS
2741
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$71.1K ﹤0.01%
151,200
STIM icon
2742
Neuronetics
STIM
$220M
$69.1K ﹤0.01%
51,195
-50,290
-50% -$88.1K
GRND.WS
2743
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$68.7K ﹤0.01%
+87,000
New +$65.5K
AVGR
2744
DELISTED
Avinger, Inc. Common Stock
AVGR
$68.6K ﹤0.01%
+12,733
New +$118K
WHLM
2745
DELISTED
Wilhelmina International, Inc
WHLM
$68.2K ﹤0.01%
19,277
NPWR.WS icon
2746
NET Power Inc Warrants
NPWR.WS
$26.2M
$67.4K ﹤0.01%
+15,535
New +$60.5K
APEI icon
2747
American Public Education
APEI
$846M
$67.3K ﹤0.01%
+13,504
New +$69.2K
RJET
2748
Republic Airways Holdings
RJET
$879M
$65.1K ﹤0.01%
5,051
-14,495
-74% -$376K
CTMX icon
2749
CytomX Therapeutics
CTMX
$717M
$64.6K ﹤0.01%
50,092
-88,355
-64% -$139K
SHCR
2750
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$64.4K ﹤0.01%
+68,435
New +$81.7K

Similar funds

John Overdeck's Q3 2023 Portfolio in Review

As of Q3 2023, John Overdeck held 3,402 positions worth $37.2B, down 6.8% from $39.9B the previous quarter. Its ten largest holdings account for 7% of the portfolio.

John Overdeck withdrew a net $1.95B in Q3 2023, closing 472 positions and reducing 1,183 holdings. Its most notable exit was Etsy, an estimated $144M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, John Overdeck opened a new position in Eli Lilly worth $232M.

  • John Overdeck's largest Q3 2023 buy was Eli Lilly: 432,734 shares worth $232M.
  • John Overdeck added most to Advanced Micro Devices in Q3 2023, an estimated $275M increase.
  • John Overdeck's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $236M.
  • John Overdeck fully exited Etsy in Q3 2023, selling an estimated $144M.
  • John Overdeck's ten largest holdings make up 7% of its $37.2B portfolio in Q3 2023.
  • John Overdeck opened 430 new positions and closed 472 in Q3 2023.
  • John Overdeck's portfolio value fell 6.8% quarter-over-quarter to $37.2B.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.